Drug intelligence / Profile preview

ampicillin + neomycin

Development stage
Unknown
Lead developer
Vet-Agro
Modality
Small Molecules
Administration
Oral, Vaginal
01

Overview

Ampicillin + neomycin is a combination of two broad-spectrum antibiotics: ampicillin, a beta-lactam penicillin, and neomycin, an aminoglycoside. Ampicillin acts primarily on Gram-positive bacteria by binding to penicillin-binding proteins (PBPs) and inhibiting bacterial cell wall synthesis. Neomycin acts primarily on Gram-negative bacteria by binding to the 30S ribosomal subunit and inhibiting bacterial protein synthesis. This combination is approved for veterinary use in Europe (under brand names such as Metriguard and Metrisan AN) as an intrauterine suspension to treat endometritis and metritis in cattle. It is also commonly used in laboratory research as an oral antibiotic cocktail to deplete gut microbiota in animal models.

Brand names
MetriguardMetrisan AN
Other names
ampicillin and neomycinampicillin/neomycin
02

Targets

Bacterial RibosomePBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on ampicillin + neomycin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ampicillin + neomycin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call